Clinical evaluation of cefamandole nafate.

Conversion of cefamandole nafate to cefamandole sodium.

Hydrolysis of cefamandole nafate in dialysis patients.

Electrochemical analysis of the cephalosporin cefamandole nafate.

Comparison of cefamandole nafate to cefamandole by microbiological assay.

Effect of cefamandole nafate on the toxicity of tobramycin.

Effect of cefamandole nafate on blood coagulation and platelet function.

Delineation of the relative antibacterial activity of cefamandole and cefamandole nafate.

Clinical and laboratory evaluation of cefamandole in infants and children.

In vitro evaluation of cefoxitin and cefamandole.

Clinical and laboratory evaluation of cefamandole in the therapy of Haemophilus spp. Bronchopulmonary infections.

Cefamandole: in vitro and clinical pharmacokinetics.

Clinical pharmacology of cefamandole as compared with cephalothin.

Cefamandole and beta-lactamases.

Cefamandole therapy in anaerobic infections.

Clinical and laboratory investigation of cefamandole in infections of infants and children.

Pharmacokinetics of cefamandole in infants and children.

Penetration of cefamandole into spinal fluid.

Antimicrobial activity of cefamandole against Salmonella typhi.

In vitro synergy of cefamandole-tobramycin combinations.

Cefamandole concentrations in pulmonary and subcutaneous tissue.

Pharmacological studies with cefamandole in human volunteers.

Pharmacokinetics and safety of cefamandole in infants and children.

Treatment of obstetric and gynecologic infections with cefamandole.

Double-blind comparison of cefamandole and penicillin in pneumococcal pneumonia.

Suggest Documents

Conversion of cefamandole nafate to cefamandole sodium.

Hydrolysis of cefamandole nafate in dialysis patients.

Electrochemical analysis of the cephalosporin cefamandole nafate.

Comparison of cefamandole nafate to cefamandole by microbiological assay.

Effect of cefamandole nafate on the toxicity of tobramycin.

Effect of cefamandole nafate on blood coagulation and platelet function.

Delineation of the relative antibacterial activity of cefamandole and cefamandole nafate.

Clinical and laboratory evaluation of cefamandole in infants and children.

In vitro evaluation of cefoxitin and cefamandole.

Clinical and laboratory evaluation of cefamandole in the therapy of Haemophilus spp. Bronchopulmonary infections.

Cefamandole: in vitro and clinical pharmacokinetics.

Clinical pharmacology of cefamandole as compared with cephalothin.

Cefamandole and beta-lactamases.

Cefamandole therapy in anaerobic infections.

Clinical and laboratory investigation of cefamandole in infections of infants and children.

Pharmacokinetics of cefamandole in infants and children.

Penetration of cefamandole into spinal fluid.

Antimicrobial activity of cefamandole against Salmonella typhi.

In vitro synergy of cefamandole-tobramycin combinations.

Cefamandole concentrations in pulmonary and subcutaneous tissue.

Pharmacological studies with cefamandole in human volunteers.

Pharmacokinetics and safety of cefamandole in infants and children.

Treatment of obstetric and gynecologic infections with cefamandole.

Double-blind comparison of cefamandole and penicillin in pneumococcal pneumonia.

Clinical evaluation of cefamandole nafate.

Recommend Documents

Follow Us